Treating ALS with stem cell injections: A clinical trial
Dr. Eva Feldman, a neurologist, researcher and director of the A. Alfred Taubman Biomedical Research Institute at the University of Michigan, is the principal investigator for a landmark clinical trial involving patients with amyotrophic lateral sclerosis, also known as ALS or Lou Gehrig's disease. The FDA-approved trial, which currently is in the safety phase, involves injecting hundreds of thousands of stem cells into the spinal cords of patients with ALS. As Dr. Feldman explains in this video, it is hoped that the stem cells will provide a healthier environment for the patients' own nerve cells, preserving function and improving quality of life.
Visiting Professor lecture to feature genetics expert
Brendan Lee, M.D., Ph.D., a genetics expert from Baylor College of Medicine, will headline the Pediatrics Research Symposium Oct. 6 at the U-M Medical School.
Click here for details and registration information.
New U-M President visits Taubman Institute
The Institute hosted a fellow clinician-scientist when the University of Michigan’s new president paid a visit to the A. Alfred Taubman Biomedical Science Research Building.
People who care
Institute welcomes new gift officer
Maria Muller has been appointed to work with connect donors with funding opportunities at the Taubman Institute.
Click here to read more.
news & events
Institute symposium set for Oct. 10
The A. Alfred Taubman Medical Research Institute will award the 2014 $100,000 Taubman Prize for Excellence in Translational Medical Science at its 7th annual symposium at 10 a.m. on Oct. 10.
Dr. Carl June, a physician-scientist who developed a personalized immunotherapy for leukemia using patients’ own T cells, will receive the honor and deliver the symposium's keynote address.
Click here for symposium details.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Study: Two types of cancer stem cells lead to metastasis
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to a new study published by Taubman Senior Scholar Dr. Max Wicha.